Viatris Inc. is a global healthcare and pharmaceutical company headquartered in Canonsburg, Pennsylvania, United States. It focuses on expanding access to a broad range of trusted, quality medications across both noncommunicable and infectious diseases, serving patients in developed and emerging markets worldwide. Viatris markets a diversified portfolio that includes branded and generic prescription drugs, complex medicines, biosimilars, and over-the-counter products, covering more than ten major therapeutic areas such as cardiovascular, oncology, infectious disease, respiratory, diabetes, and women’s health. The company operates through four primary geographic segments: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets, reflecting its broad international footprint. Viatris supplies medicines to patients, hospitals, clinics, and pharmacies via wholesalers, distributors, institutional and specialty pharmacies, and e-commerce channels across the Americas, Europe, Asia, Africa, and the Middle East. Founded in 1961 and headquartered in Canonsburg, Pennsylvania, Viatris plays a significant role in global access to pharmaceuticals, including being a leading supplier of antiretroviral treatments in low- and lower-middle-income countries.
WebsiteRobert J. Coury Global Center
Canonsburg, PA, 15317
United States
Viatris seeks court approval to launch generic Wegovy (semaglutide), challenging Novo Nordisk’s Orange Book patent. Read more here.
Investing.com -- Viatris filed a lawsuit against Novo Nordisk in Delaware federal court, requesting a determination that its planned generic version of Wegovy would not violate the Danish company's patent rights.
Investors talking about VTRS also mention
What share of all stock conversation is about VTRS?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% +0 | 0% +0 | 0% 0 | 0% 0 |
Of the messages about VTRS that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% new | 20% -80 | 69.23% -21.68 | 61.82% -21.8 | ||
| Bearish | 0% -100 | 80% new | 30.77% +21.68 | 38.18% +21.8 |
Of the messages about VTRS that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 0% | 48.15% | 46.67% | 21.32% | ||
| Technical Analysis | 100% | 14.81% | 31.11% | 16.91% | ||
| Analysts | 0% | 0% | 0% | 20.23% | ||
| Controversies | 0% | 37.04% | 22.22% | 3.72% | ||
| Earnings | 0% | 0% | 0% | 20.52% | ||
| Macro | 0% | 0% | 0% | 17.31% |
Of the messages about VTRS, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 33.82% | 56.56% | 20.14% | ||
| Newcomers | 100% | 66.18% | 43.44% | 79.86% |